These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

311 related articles for article (PubMed ID: 37029108)

  • 1. Cdc2-like kinases: structure, biological function, and therapeutic targets for diseases.
    Song M; Pang L; Zhang M; Qu Y; Laster KV; Dong Z
    Signal Transduct Target Ther; 2023 Apr; 8(1):148. PubMed ID: 37029108
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Mobilization of a splicing factor through a nuclear kinase-kinase complex.
    Aubol BE; Keshwani MM; Fattet L; Adams JA
    Biochem J; 2018 Feb; 475(3):677-690. PubMed ID: 29335301
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Conserved proline-directed phosphorylation regulates SR protein conformation and splicing function.
    Keshwani MM; Aubol BE; Fattet L; Ma CT; Qiu J; Jennings PA; Fu XD; Adams JA
    Biochem J; 2015 Mar; 466(2):311-22. PubMed ID: 25529026
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Dual-Specificity, Tyrosine Phosphorylation-Regulated Kinases (DYRKs) and cdc2-Like Kinases (CLKs) in Human Disease, an Overview.
    Lindberg MF; Meijer L
    Int J Mol Sci; 2021 Jun; 22(11):. PubMed ID: 34205123
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Disordered protein interactions for an ordered cellular transition: Cdc2-like kinase 1 is transported to the nucleus via its Ser-Arg protein substrate.
    George A; Aubol BE; Fattet L; Adams JA
    J Biol Chem; 2019 Jun; 294(24):9631-9641. PubMed ID: 31064840
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A critical update on the strategies towards small molecule inhibitors targeting Serine/arginine-rich (SR) proteins and Serine/arginine-rich proteins related kinases in alternative splicing.
    Tang J; Xie Y; Huang J; Zhang L; Jiang W; Li Z; Bian J
    Bioorg Med Chem; 2022 Sep; 70():116921. PubMed ID: 35863237
    [TBL] [Abstract][Full Text] [Related]  

  • 7. N-terminus of the protein kinase CLK1 induces SR protein hyperphosphorylation.
    Aubol BE; Plocinik RM; Keshwani MM; McGlone ML; Hagopian JC; Ghosh G; Fu XD; Adams JA
    Biochem J; 2014 Aug; 462(1):143-52. PubMed ID: 24869919
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Human CDC2-like kinase 1 (CLK1): a novel target for Alzheimer's disease.
    Jain P; Karthikeyan C; Moorthy NS; Waiker DK; Jain AK; Trivedi P
    Curr Drug Targets; 2014 May; 15(5):539-50. PubMed ID: 24568585
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Leucettines, a class of potent inhibitors of cdc2-like kinases and dual specificity, tyrosine phosphorylation regulated kinases derived from the marine sponge leucettamine B: modulation of alternative pre-RNA splicing.
    Debdab M; Carreaux F; Renault S; Soundararajan M; Fedorov O; Filippakopoulos P; Lozach O; Babault L; Tahtouh T; Baratte B; Ogawa Y; Hagiwara M; Eisenreich A; Rauch U; Knapp S; Meijer L; Bazureau JP
    J Med Chem; 2011 Jun; 54(12):4172-86. PubMed ID: 21615147
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Inhibitors of CLK protein kinases suppress cell growth and induce apoptosis by modulating pre-mRNA splicing.
    Araki S; Dairiki R; Nakayama Y; Murai A; Miyashita R; Iwatani M; Nomura T; Nakanishi O
    PLoS One; 2015; 10(1):e0116929. PubMed ID: 25581376
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A conserved sequence motif bridges two protein kinases for enhanced phosphorylation and nuclear function of a splicing factor.
    Aubol BE; Fattet L; Adams JA
    FEBS J; 2021 Jan; 288(2):566-581. PubMed ID: 32359191
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Structural Basis for the Selective Inhibition of Cdc2-Like Kinases by CX-4945.
    Lee JY; Yun JS; Kim WK; Chun HS; Jin H; Cho S; Chang JH
    Biomed Res Int; 2019; 2019():6125068. PubMed ID: 31531359
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Exploring the roles of the Cdc2-like kinases in cancers.
    Blackie AC; Foley DJ
    Bioorg Med Chem; 2022 Sep; 70():116914. PubMed ID: 35872347
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Development of Cdc2-like Kinase 2 Inhibitors: Achievements and Future Directions.
    Qin Z; Qin L; Feng X; Li Z; Bian J
    J Med Chem; 2021 Sep; 64(18):13191-13211. PubMed ID: 34519506
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Kinase domain insertions define distinct roles of CLK kinases in SR protein phosphorylation.
    Bullock AN; Das S; Debreczeni JE; Rellos P; Fedorov O; Niesen FH; Guo K; Papagrigoriou E; Amos AL; Cho S; Turk BE; Ghosh G; Knapp S
    Structure; 2009 Mar; 17(3):352-62. PubMed ID: 19278650
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Manipulation of alternative splicing by a newly developed inhibitor of Clks.
    Muraki M; Ohkawara B; Hosoya T; Onogi H; Koizumi J; Koizumi T; Sumi K; Yomoda J; Murray MV; Kimura H; Furuichi K; Shibuya H; Krainer AR; Suzuki M; Hagiwara M
    J Biol Chem; 2004 Jun; 279(23):24246-54. PubMed ID: 15010457
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Combination of Clk family kinase and SRp75 modulates alternative splicing of Adenovirus E1A.
    Yomoda J; Muraki M; Kataoka N; Hosoya T; Suzuki M; Hagiwara M; Kimura H
    Genes Cells; 2008 Mar; 13(3):233-44. PubMed ID: 18298798
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Akt2 regulation of Cdc2-like kinases (Clk/Sty), serine/arginine-rich (SR) protein phosphorylation, and insulin-induced alternative splicing of PKCbetaII messenger ribonucleic acid.
    Jiang K; Patel NA; Watson JE; Apostolatos H; Kleiman E; Hanson O; Hagiwara M; Cooper DR
    Endocrinology; 2009 May; 150(5):2087-97. PubMed ID: 19116344
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Splicing kinase SRPK1 conforms to the landscape of its SR protein substrate.
    Aubol BE; Jamros MA; McGlone ML; Adams JA
    Biochemistry; 2013 Oct; 52(43):7595-605. PubMed ID: 24074032
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Mechanism of dual specificity kinase activity of DYRK1A.
    Walte A; Rüben K; Birner-Gruenberger R; Preisinger C; Bamberg-Lemper S; Hilz N; Bracher F; Becker W
    FEBS J; 2013 Sep; 280(18):4495-511. PubMed ID: 23809146
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 16.